Pathways
EQUATEQ'S OFFERINGS
EQUATEQ NEWS
BASF acquires global leader in omega-3 fatty acids for the pharmaceutical industry
Ludwigshafen, Germany - May 9, 2012 today announced the acquisition of Equateq Ltd., a global leader in the manufacture of highly concentrated omega-3 fatty acids.
Equateq has unique capability to concentrate any fatty acid, and this schematic shows our stock items of what we can deliver of the omega-3 and omega-6 long chain lipids that comprise the metabolic pathways. We can usually deliver in whatever form required, be it FFA, EE or rTG. And all of our GMP-certified fatty acids are available in commercial quantities, from 1 gram to tons.
Omega-6
LA
18:2 n-6
18:2 n-6
GLA
18:3 n-6
18:3 n-6
DGLA
20:3 n-6
20:3 n-6
AA
20:4 n-6
20:4 n-6
22:4 n-6
22:5 n-6
Omega-3
ALA
18:3 n-3
18:3 n-3
SDA
18:4 n-3
18:4 n-3
20:4 n-3
EPA
20:5 n-3
20:5 n-3
DPA
22:5 n-3
22:5 n-3
DHA
22:6 n-3
22:6 n-3